Phio Pharmaceuticals Corp. (PHIO) earnings
PHIO earnings moved a median of -3.57% by the close. Quarterly and annual PHIO reports and results, each read against the price at its own news timestamp. Back to the PHIO overview →
13 measured PHIO earnings events.
Where these PHIO earnings landedvs 13 measured PHIO earnings reactions
| Middle 50% of PHIO earnings reactions | -6.07% to +3.08% |
|---|---|
| Median reaction (to close) | -3.57% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 PHIO earnings events with a measured close landed between -6.07% and +3.08%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Phio Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +3.58% | +4.62% | |
| Form 10-Q Phio Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.87% | -6.96% | |
| Form 10-K Phio Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.85% | -0.85% | |
| Form 10-Q Phio Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.49% | +6.34% | |
| Form 10-Q Phio Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +1.14% | +4.54% | |
| Form 10-K Phio Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.11% | |
| Form 10-Q Phio Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -2.45% | -9.80% | |
| Form 10-Q Phio Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.18% | |
| Form 10-Q Phio Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.07% | |
| Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update | Press release | +0.00% | -6.07% | |
| Form 10-K Phio Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +7.68% | +3.08% | |
| Form 10-Q Phio Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -5.36% | -3.57% | |
| Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -5.36% | -3.57% |
Keep exploring
More PHIO: analyst actions → · SEC filings → · PHIO overview →